DoW Toxic Exposures Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 7, 2026
- Amount
- Program total $6M
- Closes
- Nov 19, 2026 (in 67 days)
Similar opportunities open now
- DoW Toxic Exposures Investigator Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 67 days
- DoW Toxic Exposures Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 67 days
- DoW Arthritis Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 39 days
- DoW Vision, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 60 days
- DoW Spinal Cord Injury, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 60 days
Classification and identifiers
- Solicitation number
- HT942526TERPTRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $6M
Who can apply
About this opportunity
Summary: The intent of the fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Translational Research Award (TRA) is to support translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science, or vice versa, in developing and implementing the research plan. Distinctive Features: To encourage applications that include meaningful and productive co...